How this company is giving hope for challenging neurological treatments

Looking at slides of the blood-brain-barrier. , Image courtesy of Market One Media
  • Effective treatment of neurological conditions continues to be challenging
  • Propelled by revolutionary breakthroughs in blood-brain barrier drug delivery, Bioasis Technologies brings new insights to the forefront
  • With tech partnerships, Bioasis has secured research funding for selected development programs and potentially lucrative milestone payments

“We’re going after a solution where currently none exists right now.”

— Dr. Deborah Rathjen, Executive Chair, Bioasis Technologies Inc.

Brain slides from Bioasis’s xB3 ™ platform.
Patient going in for a brain scan.
The blood-brain barrier (BBB) is a highly selective barrier that separates circulating blood from the brain and extracellular fluid in the central nervous system.



Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Market One

Market One

1 Follower

Canada’s leading marketing agency for public companies.